Invention Grant
- Patent Title: Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS
-
Application No.: US15261945Application Date: 2016-09-10
-
Publication No.: US10519237B2Publication Date: 2019-12-31
- Inventor: Michal Eisenbach-Schwartz , Kuti Baruch , Neta Rosenzweig
- Applicant: Yeda Research and Development Co. Ltd
- Applicant Address: IL Rehovot
- Assignee: Yeda Research and Development Co. Ltd
- Current Assignee: Yeda Research and Development Co. Ltd
- Current Assignee Address: IL Rehovot
- Agency: UltimatEdge IP Law Group, P.C.
- Agent Dean G. Stathakis
- Main IPC: C07K16/28
- IPC: C07K16/28 ; A61K39/395 ; A61K45/06 ; A61K31/404 ; A61K31/4155 ; A61K31/7068 ; A61K33/36 ; A61K39/00
Abstract:
The present specification discloses a pharmaceutical composition comprising an active agent that causes reduction of the level of systemic immunosuppression in an individual for use in treating a disease, disorder, condition or injury of the CNS. The pharmaceutical composition is administered by a dosage regimen comprising at least one course of therapy, each course of therapy comprising in sequence a treatment session followed by an interval session of non-treatment.
Public/Granted literature
- US20170029508A1 Reducing Systemic Regulatory T Cell Levels or Activity for Treatment of Disease and Injury of the CNS Public/Granted day:2017-02-02
Information query
